• Featured Product
  • KD/KO Validated

ACLY Monoklonaler Antikörper

ACLY Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgM

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1E10D5

Kat-Nr. : 67166-1-PBS

Synonyme

ATP citrate lyase, 1E10D5, ACL, ATP-citrate, ATP-citrate synthase



Geprüfte Anwendungen

Produktinformation

67166-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA ACLY und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Maus / IgM
Klonalität Monoklonal
Typ Antikörper
Immunogen ACLY fusion protein Ag7709
Vollständiger Name ATP citrate lyase
Berechnetes Molekulargewicht 121 kDa
Beobachtetes Molekulargewicht 120 kDa
GenBank-ZugangsnummerBC006195
Gene symbol ACLY
Gene ID (NCBI) 47
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ACLY(ATP-citrate synthase) is also named as ACL. It is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA. ACLY serves as not only a target in oxygenated cells for suppression of lipid synthesis and histone acetylation, but also as a susceptible target in hypoxic cells to restore inhibition of glycolysis. In nonsmall cell lung carcinoma and hepatocellular carcinoma, ACLY is overexpressed compared with normal parenchyma suggesting that ACLY may represent a common target among highly malignant tumors(PMID:19795461). This protein has 2 isoforms produced by alternative splicing.